NDC 71656-021-30 - POTASSIUM CHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71656-021
- Requested NDC
- 71656-021-30
- Package NDCs from labels
- 71656-021-16, 71656-021-15, 71656-021-50, 71656-021-01, 71656-021-30, 71656-021-51, 71656-021-02
- Manufacturer
- American Health Packaging
- Effective date
- 2026-09-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POTASSIUM CHLORIDE - American Health Packaging | American Health Packaging | 2026-09-23 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - Saptalis Pharmaceuticals, LLC | Saptalis Pharmaceuticals, LLC | 2026-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-08-24 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71656-021-01 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-01 | POTASSIUM CHLORIDE | 10 in 1 CASE | SOLUTION | 10 | 5 | |
| 71656-021-02 | POTASSIUM CHLORIDE | 10 in 1 CASE | SOLUTION | 10 | 5 | |
| 71656-021-02 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-15 | POTASSIUM CHLORIDE | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 5 | |
| 71656-021-16 | POTASSIUM CHLORIDE | 473 mL in 1 BOTTLE | SOLUTION | 473 | 5 | |
| 71656-021-30 | POTASSIUM CHLORIDE | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 5 | |
| 71656-021-50 | POTASSIUM CHLORIDE | 5 in 1 CASE | SOLUTION | 5 | 5 | |
| 71656-021-50 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-51 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-51 | POTASSIUM CHLORIDE | 5 in 1 CASE | SOLUTION | 5 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71656-021-01 | ML - Milliliter | 71656-021 | 6bd0ebbf-a7a4-40f2-b463-9f94ddbce7be | 1 | 2024-06-10 |
| 71656-021-15 | ML - Milliliter | 71656-021 | c27304b6-be2d-4797-aac3-a530ab28e3ba | 1 | 2024-06-10 |
| 71656-021-16 | ML - Milliliter | 71656-021 | 99d9cda5-bc17-4912-b16e-3b4dd995bd14 | 1 | 2024-08-12 |
| 71656-021-30 | ML - Milliliter | 71656-021 | 0b65870e-cf13-427b-af5f-c812d5eb9e9c | 1 | 2025-05-14 |
| 71656-021-50 | ML - Milliliter | 71656-021 | b55652f8-ada5-4d3a-a114-b9e2fbac018c | 1 | 2023-12-05 |
| 71656-021-51 | ML - Milliliter | 71656-021 | 5d529fbd-3765-4e17-9818-571896c812e3 | 1 | 2023-12-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xpect Industrial Eye Relief | GLYCERIN, NAPHAZOLINE HCL | Cintas Corporation | a0167d06-7adb-36f4-e053-2a95a90af9ef | 2025-09-30 | Warnings | PDC6A3C0OX |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Granules Pharmaceuticals Inc. | b3d4d5b5-2898-ae3d-e053-2a95a90a6d04 | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc | c1f4832d-4d5c-8c49-e053-2a95a90ac9fe | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 0e875691-7372-46ac-80a1-946e08b40061 | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Xpect Eyewash | EYEWASH | Cintas Corporation | 1d69365d-662b-4248-8fa9-1629451b549a | 2025-09-30 | Warnings | 059QF0KO0R |
| CheBoho TEA TREE ACNE | CHEBOHO TEA TREE ACNE | Opalshi(Guangzhou)E-commerce Co. Ltd. | 3fc4cf84-b2da-c593-e063-6394a90abc5c | 2025-09-27 | Warnings | 059QF0KO0R |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF CREAM | Neilmed Pharmaceuticals Inc. | 374dc1c0-4243-b272-e063-6394a90a5a6b | 2025-09-24 | Warnings | PDC6A3C0OX |
| Potassium Chloride | POTASSIUM CHLORIDE | Epic Pharma, LLC | 00615fad-ad3b-46e8-a89d-48290d937ae2 | 2025-09-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Macleods Pharmaceuticals Limited | 89d827c8-91af-4bfd-a846-62e55824e983 | 2025-09-22 | Warnings, Adverse reactions | 314182 312515 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | a9d68a40-75e3-4c5c-b5d7-1d6160527fa7 | 2025-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Sterile Water | WATER | ProPharma Distribution | 3f2ae880-852f-b45d-e063-6394a90aa1cc | 2025-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| Potassium Chloride | POTASSIUM CHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 542e16b0-44db-490f-b44e-4c88a6e3d8b8 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Strides Pharma Science Limited | 0224e5b3-3c49-4e6e-aa78-1abcc6969246 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | 660YQ98I10 |
| REFRESH OPTIVE Drops | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 80275190-d717-40ea-905b-5c8fbe986eac | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva PF Xtra | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | b51b8a75-8faa-430f-8f7e-ee58d3d13f2e | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 6b984fa2-4187-45ef-b7d3-15e720abc667 | 2025-09-15 | Warnings | PDC6A3C0OX |
| Dry eye relief | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | f8da3af5-9172-4023-be82-0fd5bd891616 | 2025-09-12 | Warnings | 6DC9Q167V3 |
| Oasis Tears PF Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 640f95f4-c2e8-48ad-ad40-f76bbaddb0dc | 2025-09-12 | Warnings | PDC6A3C0OX |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.